Filing Details

Accession Number:
0000313143-13-000197
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-12-03 13:22:37
Reporting Period:
2013-12-02
Filing Date:
2013-12-03
Accepted Time:
2013-12-03 13:22:37
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
313143 Haemonetics Corp HAE Surgical & Medical Instruments & Apparatus (3841) 042882273
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1261784 Brian Concannon 400 Wood Road
Braintree MA 02184
President & Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2013-12-02 4,600 $25.54 134,907 No 4 M Direct
Common Stock Disposition 2013-12-02 4,600 $42.29 130,307 No 4 S Direct
Common Stock Acquisiton 2013-12-02 3,000 $13.05 133,307 No 4 M Direct
Common Stock Disposition 2013-12-02 3,000 $42.33 130,307 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Non-Qualified Stock Option (right to buy) Disposition 2013-12-02 3,000 $42.33 3,000 $13.05
Common Stock Non-Qualified Stock Option (right to buy) Disposition 2013-12-02 4,600 $42.29 4,600 $25.54
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
6,000 2005-05-05 2014-05-05 No 4 M Direct
36,580 2008-10-24 2014-10-24 No 4 M Direct
Reported Derivative Holdings
Sec. Name Sec. Type Price Date Expiration Date Amount Remaning Holdings Nature of Ownership
Common Stock Non-Qualified Stock Option (right to buy) $26.47 2010-10-27 2016-10-27 159,350 159,350 Direct
Common Stock Non-Qualified Stock Option (right to buy) $27.28 2009-10-22 2015-10-22 57,176 57,176 Direct
Common Stock Non-Qualified Stock Option (right to buy) $27.50 2011-10-27 2017-10-27 236,750 236,750 Direct
Common Stock Non-Qualified Stock Option (right to buy) $27.69 2010-04-02 2016-04-02 65,690 65,690 Direct
Common Stock Non-Qualified Stock Option (right to buy) $30.67 2012-10-25 2018-10-25 219,572 219,572 Direct
Common Stock Non-Qualified Stock Option (right to buy) $39.06 2013-10-24 2019-10-24 250,382 250,382 Direct
Common Stock Non-Qualified Stock Option (right to buy) $41.66 2014-10-23 2019-10-23 234,899 234,899 Direct
Common Stock Performance Shares $0.00 2017-03-31 2017-12-31 50,000 50,000 Direct
Expiration Date Amount Remaning Holdings Nature of Ownership
2016-10-27 159,350 159,350 Direct
2015-10-22 57,176 57,176 Direct
2017-10-27 236,750 236,750 Direct
2016-04-02 65,690 65,690 Direct
2018-10-25 219,572 219,572 Direct
2019-10-24 250,382 250,382 Direct
2019-10-23 234,899 234,899 Direct
2017-12-31 50,000 50,000 Direct
Footnotes
  1. Pursuant to a 10b5-1 Plan.
  2. Grant to reporting person of right to buy shares of common stock exercisable in annual increments of 25 percent beginning on the first anniversary of the date of grant.
  3. Market Share Units represent a right to receive one share of Haemonetics Corporation common stock for each Market Stock Unit based on Haemonetics stock price during the 30 trading days prior to March 31, 2017. The number of Market Stock Units (and therefore the number of shares payable) will depend on the Companys stock price during such period. The Market Stock Units disclosed in column 5 represent a target amount. The number of shares ultimately issued could range from none to three times the target amount in column 5. The Market Stock Units were granted under the 2005 Haemonetics Corporation Long-Term Incentive Compensation Plan and are exempt under Rule 16b-3(d).